Gary Palmer

This inventor holds 8 USPTO granted patents and 14 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Foundation Medicine, Inc., Mts Holdings, Inc.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary Palmer. Retrieved from https://idiyas.com/inventor/gary-palmer-ts6iu94f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 14)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 17(Granted Patents)

Location History:

Fort Lauderdale, FL (US) (2015)
Waltham, MA (US) (2018 - 2024)

Company Filing History:

7 out of 47

Foundation Medicine, Inc.

Years Active: 2015-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12548682 - System and method for outcome tracking and analysis (2026-02-10),

2. 12116638 - Estrogen receptor mutations and uses thereof (2024-10-15),

3. 12087453 - System and method for outcome tracking and analysis (2024-09-10),

4. 11450438 - System and method for outcome tracking and analysis (2022-09-20),

5. 11286532 - Estrogen receptor mutations and uses thereof (2022-03-29),

6. 11158425 - System and method for managing genomic information (2021-10-26),

7. 10093983 - Estrogen receptor mutations and uses thereof (2018-10-09),

8. 9183549 - System and method of secure payment transactions (2015-11-10),

Title: Gary Palmer: Innovator in Cancer Treatment Technologies

Introduction

Gary Palmer is a notable inventor based in Waltham, MA (US), recognized for his contributions to cancer treatment technologies. With a total of seven patents to his name, Palmer has made significant strides in the field of oncology through innovative systems and methods.

Latest Patents

Among his latest patents is a groundbreaking invention related to estrogen receptor mutations. This patent discloses novel mutant ESR1 molecules and their various uses. Another significant patent focuses on a system and method for outcome tracking and analysis. This system captures outcome information associated with various cancer treatments, facilitating the analysis of treatment data and genomic alterations. The system is designed to store and analyze information related to tumor types, genomic alterations, and treatment data, ultimately aiding in diagnosis and therapy decisions.

Career Highlights

Throughout his career, Gary Palmer has worked with prominent companies in the healthcare sector, including Foundation Medicine, Inc. and MTS Holdings, Inc. His work has been pivotal in advancing cancer treatment methodologies and improving patient outcomes.

Collaborations

Palmer has collaborated with esteemed colleagues such as Vincent A. Miller and Philip James Stephens, contributing to the development of innovative solutions in cancer treatment.

Conclusion

Gary Palmer's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment technologies. His patents and collaborations reflect a commitment to improving patient care through advanced research and development.

Profile summary based on public USPTO records.